|
WO2020087116A1
|
|
Bispecific polypeptides for engagement of car expressing immune cells with antigen presenting cells and uses thereof
|
|
WO2020000035A1
|
|
Modified t cells and uses thereof
|
|
WO2018009972A1
|
|
Chimeric antigen receptor modified t cells
|
|
WO2017201573A1
|
|
A method of classification and treatment
|
|
WO2016172764A1
|
|
Breast cancer risk assessment
|
|
US2017260510A1
|
|
Leukaemia stem cell line, its method of production and uses thereof
|
|
WO2015172201A1
|
|
Biomarker of gastric cancer
|
|
WO2014161037A1
|
|
Antibodies against human ryk and uses therefor
|
|
AU2013305475A1
|
|
Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof
|
|
AU2012101273A4
|
|
System and process for cancer risk estimation
|
|
WO2012031320A1
|
|
Cancer diagnostic
|
|
EP2585060A1
|
|
Stimulating immune response
|
|
CA2795370A1
|
|
Radioprotector compounds and methods
|
|
AU2010236016A1
|
|
Method of treatment of EGFR inhibitor toxicity
|
|
WO2011006214A1
|
|
Method of detecting radiation exposure and adverse toxicity thereto
|
|
AU2009222562A1
|
|
Cancer therapy
|
|
US2011171642A1
|
|
Analysing Methylation Specific PCR by Amplicon Melting
|
|
CN101605763A
|
|
Radioprotector compounds and methods involving
|
|
WO2006110950A1
|
|
In vivo model for preclinical drug development
|
|
AU2005313864A1
|
|
Methods and compositions for adoptive immunotherapy
|
